At the IGTP TODAY
An international study, published in The Lancet, demonstrates for the first time that the drug selumetinib is effective in reducing tumours and associated pain in adults with neurofibromatosis type 1 (NF1). IGTP and Hospital played a key role in the clinical trial, which marks a significant advance in the treatment options for this rare genetic disease.
The Innomed program, an initiative led and coordinated by the IGTP, has concluded the second edition of its GrowInn project incubator with the celebration of the Innomed Awards, which have gathered over 150 people and recognised five projects for their talent and determination.
_1750336882.jpeg)
The first CORE IGTP Scientific Conference was held at the Badalona International Business Centre (BCIN), an initiative of the CORE Program that aims to establish itself as an annual space for meeting, debate and scientific exchange among professionals involved in population health research.
Researchers from ICREC-IGTP have conducted a preclinical study on the effects of the drug empagliflozin, alone or in combination with sacubitril/valsartan, in the early phase following a myocardial infarction. The combination of the two showed promising results.
Researchers from the Experimental Tuberculosis Unit (UTE) at the IGTP and the Germans Trias i Pujol University Hospital have published a study in Nature Communications in which, for the first time, the transcriptomic profile of human tuberculosis lung lesions is correlated with clinical data from the same patients.
Researchers from IGTP analysed in-hospital mortality in 5,813 COVID-19 patients across four epidemic waves in Catalonia, focusing on whether patients had a ceiling of care. Mortality decreased significantly over time for patients without a ceiling of care, but remained consistently high in those with one. These findings underscore the need to account for ceiling of care when evaluating COVID-19 outcomes and planning future healthcare responses.
The IGTP, through the INEDIT group, is involved in three major European projects committed to health innovation, with over €12 million in funding.
_1749029861.JPG)
On 2 June, IGTP hosted the kick-off event for the DM1-Hub, a multicentre project driven by the the group GRENBA, which aims to create a comprehensive national registry of patients with Myotonic Dystrophy type 1 (DM1). The event brought together researchers, clinical professionals, institutional representatives and patient associations from across Spain.
TESTA'T Jove-iCONNECTA project, a leading initiative in public health and funded by La Marató de TV3 that seeks to improve the diagnosis, prevention and access to the treatment of sexually transmitted infections (STI) and HIV among young people in Catalonia.
The episode features Eva Martínez-Cáceres and Cristina Ramo. Together, they explain the basics of multiple sclerosis and the research they are conducting. The episode also includes the testimony of a patient, who shares what it is like to live with the disease.
